Niraparib tosylate monohydrate

Niraparib tosylate monohydrate (CAS: 1613220-15-7) is a high-purity pharmaceutical grade small-molecule organic compound and a potent selective PARP inhibitor. Niraparib tosylate monohydrate 1613220-15-7 exists as white to off-white crystalline solid powder at room temperature, with stable chemical properties under low-temperature sealed storage. It specifically inhibits the activity of PARP1 and PARP2 enzymes, blocks tumor cell DNA repair pathways, and is a core active raw material widely used in anti-tumor drug synthesis, pharmaceutical research and biomedical oncological mechanism research.

MK-4827 tosylate hydrate, Niraparib tosylate hydrate, Niraparib monohydrate tosylate

2933990090

1. Anti-tumor Pharmaceutical Intermediate Synthesis: Niraparib tosylate monohydrate (1613220-15-7) serves as a key synthetic intermediate for targeted anti-cancer drugs. It is applied in the fine chemical synthesis of PARP inhibitor anti-tumor preparations, ensuring high purity and biological activity of finished pharmaceutical products for clinical tumor treatment. 2. PARP Targeted Anti-cancer Drug R&D: Niraparib tosylate monohydrate 1613220-15-7 targets and inhibits PARP1 and PARP2 enzyme activities, effectively interfering with tumor DNA repair. It is widely used in preclinical research and new drug development for ovarian cancer, breast cancer and other malignant tumors, supporting the innovation of targeted anti-tumor therapeutics. 3. Biomedical Oncological Pharmacological Research: As a professional tumor research reagent, Niraparib tosylate monohydrate (CAS 1613220-15-7) is commonly used in laboratory research on tumor cell apoptosis, DNA damage repair mechanisms and drug efficacy verification, providing reliable raw material support for academic and industrial biomedical research projects.

99% Min (HPLC)

C26H30N4O5S

510.61

2 years under proper storage

White to off-white crystalline solid powder

Pharmaceutical Grade, Research Grade

Not available

Not available